Global Health Ltd appoints Health Metrics founder Steven Strange to board


Global Health Ltd (ASX:GLH) has appointed Steven Strange, founder of aged care software provider Health Metrics (HM), as non-executive director.

Strange brings 30 years of healthcare industry leadership experience to the board.

Strange is a full member of the Australian Computer Society (MACS), a fellow of the Australian Institute of Company Directors (MAICD) and holds qualifications in computing and law from Monash University, including an MSc from information.

30 years of management experience

Strange was the founder and chief executive of HM, a leading provider of software solutions for the elderly care industry.

He also recently successfully completed the sale of HM to private equity firms.

Strange brings more than 30 years of leadership experience to the Global Health Board of Directors at an opportune and crucial time, when the company seeks to significantly expand its business both domestically and in its positioning in the Asia- Peaceful.

Good understanding of healthcare models

The ongoing digitization of the healthcare industry, accelerated by the global pandemic, also highlights why Strange’s skills will be a welcome addition to the board.

At HM, this experience was clearly demonstrated where Strange led and oversaw the execution of HM’s overall strategy.

This involved, among other things, bringing technological products to local and international markets.

Through this process, Strange has developed a strong understanding of healthcare models, globally.

“Defines global health very well”

Global Health Chairman Steven Pynt expressed excitement over Strange’s appointment to the board and said, “Global Health’s board has always been characterized by demonstrable depth of business, industry and global experience that allows easy access for the CEO. and the management team to seek out and obtain excellent advice at all times.

“The handover from Mr. Robert Knowles AO to Mr. Steven Strange is further evidence of this and puts Global Health very well within its current growth cycle for the challenges ahead.”


Comments are closed.